A: The philosophy behind oxidative therapies is a simple one. The use of ozone in medicine is based on the belief that the accumulation of toxins in the body is normally burnt up by the process of oxidation, a process wherein a substance is changed chemically because of the effect of oxygen on it. Oxidation breaks the toxins down into carbon dioxide and water, and eliminates them from the body. However, if the oxygen system of the body is weak or deficient (whether through lack of exercise, environmental pollution, poor diet, smoking, or improper breathing), our bodies cannot eliminate them adequately and a toxic reaction can occur. In minor cases, a toxic buildup can lead to fatigue, while a wide range of diseases can result when poor oxygenation is chronic.
A: Although few of us have ever heard of them, ozone therapies have been around for a long time. They have been used clinically by European physicians for over a century, and were first reported by Dr. T.H. Oliver in the British medical publication The Lancet in 1920. Since that time, they have been studied in major medical research centers throughout the world, including Baylor University, Yale University, The University of California (Los Angeles) and Harvard University in the United States, as well as in medical schools and laboratories in Great Britain, Germany, Italy, Russia, Canada, Japan and Cuba. Today, there are many scientific articles are published each month about the chemical and biological effects of ozone.
According to Frank Shallenberger, M.D., who is best known in the United States for treating AIDS patients with a holistic protocol including ozone, bio-oxidative therapies have affect the human body in the following ways:
Because ozone was found to be an effective bactericide and fungicide during the mid-1800’s, it was first used to purify drinking water in a number of European cities. Today, over 2000 municipalities around the world- including Montreal, Paris, Los Angeles and Moscow- purify their drinking water with ozone. However, ozone was not used medically until 1915, when it was found to be an effective disinfectant of wounds and skin diseases in Germany during the First World War. It was later found that ozone has the ability to “blast” holes through the membranes of viruses, yeasts, bacteria and abnormal tissue cells and therefore killing them. Ozone was the focus of considerable research in Germany during the 1930’s where it was successfully used to treat patients suffering from inflammatory bowel disorders, ulcerative colitis, Crohn’s disease and chronic bacterial diarrhea. The four primary ways to administer medical ozone include:
A: Ozone therapies offer a tremendous range of medical applications. According to the International Bio-Oxidative Medical Foundation (IBOMF), an Oklahoma-based organization devoted to research and education about these therapies, the following conditions or diseases have been treated with ozone to varying degrees of success:
A: There is growing evidence that ozone (as well as hydrogen peroxide, since ozone becomes transformed into hydrogen peroxide in the body) can destroy lipid-enveloped viruses both outside and within the body, including those related to hepatitis, Epstein -Barr, cancer, herpes, cytomegalovirus and HIV. The results of a study coordinated by the Canadian Armed Forces and published in the Canadian Medical Association Journal showed that ozone kills HIV, the hepatitis and herpes viruses, and other harmful agents in the blood used for transfusion. The author of the article added, “The systemic use of ozone in the treatment of AIDS could not only reduce the virus load, but also possibly revitalize the immune system. ” Although a related study on AIDS patients proved inconclusive, Cmdr. Michael Shannon, MD, one of the coordinators of the study, wrote that “Of interest, however, the three patients (out of ten volunteers) who responded to minor autohemotherapy in the first trial, are still alive after four years post treatment, with CD4 counts in excess of two hundred. These patients should have theoretically succumbed to AIDS within a year post-treatment.” In several clinics in Germany, AIDS patients are being treated successfully with different types of ozone therapies, including rectal insufflation, ozone bagging, and autohemotherapy.
Bio-oxidative therapies can be an important part of holistic treatment for HIV-related problems, including lower T-cell counts, opportunistic infections, and AIDS-related diarrhea. Dan’s was one such case. He was diagnosed HIV-positive and his T-cell count had dropped below 600. After only one month of ozone therapy as part of a protocol including vitamin supplements, anti-viral compounds and intestinal cleansing, his T-cell count rose to 900 and his swollen lymph nodes shrank for the first time in years.
Although there have been other cases of improvement of AIDS patients after regular ozone treatments (and several documented cases of people who were HIV+ reverting to HIV- status) ozone and hydrogen peroxide should not be considered as a “magic bullet” against HIV and AIDS. According to Frank Shallenberger, M.D. “Ozone therapy works in AIDS by acting as a an immune system modulator. In this capacity, it is very effective, safe, inexpensive and readily available. Proper therapy for AIDS will be directed at early intervention (i.e. CD4 count > 300), ozone plus other synergistic immune-augmented therapy, intestinal cleansing is paramount due to the immuno-suppressive aspect of parasites.
Dr. Silvia Menendez, the co-founder of Cuba’s Department of Ozone Department (part of the prestigious National Center for Scientific Research in Havana), suggested that ozone works best when administered as soon as possible after HIV infection, before the virus has penetrated the lymphatic system and bone marrow. The personal, economic and social ramifications of this possibility cannot be underestimated.
A: Although ozone is highly toxic in its purified state, it has been found to be both safe and effective when diluted to therapeutic levels for medical use. When administered in prescribed amounts by a qualified practitioner, the chances of experiencing adverse reactions to bio-oxidative therapies are extremely small. For example, a German study on 384,775 patients evaluating the adverse side effects of over five million medically-administered ozone treatments found that the rate of adverse side effects was only 0.0007 per application. This figure is far lower than any other type of medical therapy.
It has been estimated that over ten million people (primarily in Germany, Russia and Cuba) have been given bio-oxidative therapies over the past seventy years to treat over fifty different diseases. As cited before, they include heart and blood vessel diseases, diseases of the lungs, infectious diseases, and immune-related disorders. In some cases, bio-oxidative therapies are administered alone, while in others, they are used in addition to traditional medical procedures (such as surgery or chemotherapy) or as adjuncts to alternative health practices like megavitamin therapy, acupuncture or herbal medicine.
A: Despite the fact that ozone therapy has been proven in clinical trials (and in regular clinical practice) to be safe and effective in Germany, Austria, Cuba, Mexico, Italy and Russia, very few people have heard about bio-oxidative therapies in the United States and Canada. Although an estimated 15,000 European practitioners legally use bio-oxidative therapies in their practices, the number of physicians using these therapies in North America is probably fewer than 500. This is partly due to the fact that information about medical ozone is not provided in medical schools, and students simply do not learn about them. In addition, the medical establishment (and especially provincial and state medical boards) often discourages or prevents licensed physicians from using them in their medical practice. Some have been threatened with having their licenses revoked if they administer ozone. Clinics have been closed down and practitioners have been threatened with jail.
A: A major reason for this lack of interest in bio-oxidative therapies is that ozone is a non-patentable substance that is very inexpensive to manufacture and use. In Germany, Russia and Cuba, physicians have successfully treated many serious and chronic conditions (including cancer and heart disease) without expensive surgery. The net cost of the materials for a treatment is under $10. Even though physicians must include professional fees and the use of their offices and equipment, bio-oxidative therapies administered in a medical setting cost up to fifty percent less than traditional therapies, especially for patients suffering from chronic and degenerative diseases. Self-administered treatments by patients themselves, while not recommended, can cost far less. For these reasons, ozone poses a threat to the continued dominance of the medical establishment: the pharmaceutical industry, medical centers and physicians who are accustomed to providing expensive drugs, complex medical procedures and long hospital stays.
A: Because government health agencies are often influenced by the pharmaceutical industry and medical lobbies, objective investigation and development of effective protocols for bio-oxidative therapies have been difficult to undertake. However, the Canadian government has shown a greater willingness to investigate these therapies than American government agencies like the FDA or NIH, as shown by the HIV studies cited earlier. However, like the American press, the Canadian media largely ignored the important findings that ozone can completely remove HIV, hepatitis and herpes viruses from the blood supply.
A: After reviewing the laboratory and clinical evidence regarding the use of ozone, a recent report by the National Institutes of Health (NIH) on Alternative Medical Systems and Practices in the United States has recommended that “definitive studies be undertaken to determine whether these treatments have any utility”. At the same time, a number of states- including New York and North Carolina- have recently passed “freedom of medicine” laws which allow the use of experimental therapies by licensed practitioners. Many physicians who are members of IBOMF from both Canada and the United States are sharing their clinical data with the goal of presenting their findings to government agencies like the NIH and FDA.